The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis

被引:5
|
作者
Marzec, Jacek [1 ]
Ross-Adams, Helen [1 ]
Pirro, Stefano [1 ]
Wang, Jun [1 ]
Zhu, Yanan [2 ]
Mao, Xueying [2 ]
Gadaleta, Emanuela [1 ]
Ahmad, Amar S. [3 ]
North, Bernard V. [3 ]
Kammerer-Jacquet, Solene-Florence [2 ]
Stankiewicz, Elzbieta [2 ]
Kudahetti, Sakunthala C. [2 ]
Beltran, Luis [4 ]
Ren, Guoping [5 ]
Berney, Daniel M. [2 ,4 ]
Lu, Yong-Jie [2 ]
Chelala, Claude [1 ,6 ]
机构
[1] Queen Mary Univ London, Barts Canc Inst, Bioinformat Unit, Ctr Canc Biomarkers & Biotherapeut, London EC1M 6BQ, England
[2] Queen Mary Univ London, Barts Canc Inst, Ctr Canc Biomarkers & Biotherapeut, London EC1M 6BQ, England
[3] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med, Ctr Canc Prevent, London EC1M 6BQ, England
[4] Barts Hlth NHS, Dept Pathol, London E1 F1R, England
[5] Zhejiang Univ, Med Coll, Dept Pathol, Affiliated Hosp 1, Hangzhou 310058, Peoples R China
[6] Queen Mary Univ London, Life Sci Initiat, Ctr Computat Biol, London EC1M 6BQ, England
基金
英国工程与自然科学研究理事会;
关键词
prostate cancer; tumorigenesis; mRNA; RNAseq; transcriptomic; data integration;
D O I
10.3390/cancers13020345
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary There is a tremendous amount of gene expression information available for prostate cancer, but very few tools exist to combine the disparate datasets generated across sample types and technical platforms. We present a method of integrating different types of expression data from different study cohorts to increase analytic power, and improve our understanding of the molecular changes underlying the development and progression of prostate cancer from normal to advanced disease. Using this approach, we identified nine additional disease stage-specific candidate genes with prognostic significance, which were not identified in any one study alone. We have developed a free online tool summarizing our results, and making the complete combined dataset available for further translational research. Next-generation sequencing of primary tumors is now standard for transcriptomic studies, but microarray-based data still constitute the majority of available information on other clinically valuable samples, including archive material. Using prostate cancer (PC) as a model, we developed a robust analytical framework to integrate data across different technical platforms and disease subtypes to connect distinct disease stages and reveal potentially relevant genes not identifiable from single studies alone. We reconstructed the molecular profile of PC to yield the first comprehensive insight into its development, by tracking changes in mRNA levels from normal prostate to high-grade prostatic intraepithelial neoplasia, and metastatic disease. A total of nine previously unreported stage-specific candidate genes with prognostic significance were also found. Here, we integrate gene expression data from disparate sample types, disease stages and technical platforms into one coherent whole, to give a global view of the expression changes associated with the development and progression of PC from normal tissue through to metastatic disease. Summary and individual data are available online at the Prostate Integrative Expression Database (PIXdb), a user-friendly interface designed for clinicians and laboratory researchers to facilitate translational research.
引用
收藏
页码:1 / 24
页数:25
相关论文
共 50 条
  • [1] Integrative analysis of genomic aberrations associated with prostate cancer progression
    Kim, Jung H.
    Dhanasekaran, Saravana M.
    Mehra, Rohit
    Tomlins, Scott A.
    Gu, Wenjuan
    Yu, Jianjun
    Kumar-Sinha, Chandan
    Cao, Xuhong
    Dash, Atreya
    Wang', Lei
    Ghosh, Debashis
    Shedden, Kerby
    Montie, James E.
    Rubin, Mark A.
    Pienta, Kenneth J.
    Shah, Rajal B.
    Chinnaiyan, Arul M.
    [J]. CANCER RESEARCH, 2007, 67 (17) : 8229 - 8239
  • [2] Integrative biology of prostate cancer progression
    Tomlins, Scott A.
    Rubin, Mark A.
    Chinnaiyan, Arul M.
    [J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2006, 1 (01) : 243 - 271
  • [3] Integrative Genomics of Prostate Cancer Progression
    Cyrta, Joanna
    Mosquera, Juan Miguel
    Robinson, Brian
    Sboner, Andrea
    Beltran, Himisha
    Hovelson, Daniel
    Tomlins, Scott A.
    Shen, Ronglai
    Rubin, Mark A.
    [J]. MODERN PATHOLOGY, 2017, 30 : 219A - 219A
  • [4] Integrative Genomics of Prostate Cancer Progression
    Cyrta, Joanna
    Mosquera, Juan Miguel
    Robinson, Brian
    Sboner, Andrea
    Beltran, Himisha
    Hovelson, Daniel
    Tomlins, Scott A.
    Shen, Ronglai
    Rubin, Mark A.
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 219A - 219A
  • [5] Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer
    Seong-Keun Yoo
    Young Shin Song
    Eun Kyung Lee
    Jinha Hwang
    Hwan Hee Kim
    Gyeongseo Jung
    Young A Kim
    Su-jin Kim
    Sun Wook Cho
    Jae-Kyung Won
    Eun-Jae Chung
    Jong-Yeon Shin
    Kyu Eun Lee
    Jong-Il Kim
    Young Joo Park
    Jeong-Sun Seo
    [J]. Nature Communications, 10
  • [6] Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer
    Yoo, Seong-Keun
    Song, Young Shin
    Lee, Eun Kyung
    Hwang, Jinha
    Kim, Hwan Hee
    Jung, Gyeongseo
    Kim, Young A.
    Kim, Su-jin
    Cho, Sun Wook
    Won, Jae-Kyung
    Chung, Eun-Jae
    Shin, Jong-Yeon
    Lee, Kyu Eun
    Kim, Jong-Il
    Park, Young Joo
    Seo, Jeong-Sun
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [7] Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
    Latonen, Leena
    Afyounian, Ebrahim
    Jylha, Antti
    Nattinen, Janika
    Aapola, Ulla
    Annala, Matti
    Kivinummi, Kati K.
    Tammela, Teuvo T. L.
    Beuerman, Roger W.
    Uusitalo, Hannu
    Nykter, Matti
    Visakorpi, Tapio
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [8] Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
    Leena Latonen
    Ebrahim Afyounian
    Antti Jylhä
    Janika Nättinen
    Ulla Aapola
    Matti Annala
    Kati K. Kivinummi
    Teuvo T. L. Tammela
    Roger W. Beuerman
    Hannu Uusitalo
    Matti Nykter
    Tapio Visakorpi
    [J]. Nature Communications, 9
  • [9] Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry
    Yuan, Jiao
    Kensler, Kevin H.
    Hu, Zhongyi
    Zhang, Youyou
    Zhang, Tianli
    Jiang, Junjie
    Xu, Mu
    Pan, Yutian
    Long, Meixiao
    Montone, Kathleen T.
    Tanyi, Janos L.
    Fan, Yi
    Zhang, Rugang
    Hu, Xiaowen
    Rebbeck, Timothy R.
    Zhang, Lin
    [J]. PLOS GENETICS, 2020, 16 (02):
  • [10] IMMUNE TRANSCRIPTOMIC REPERTOIRE EVALUATION IN PROSTATE CANCER PROGRESSION
    Van Booven, Derek
    Vedenko, Anastasia
    Reddy, Raghuram
    Arora, Himanshu
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E792 - E792